when fda approve compass pathways' comp360 psilocybin
Before July 2027
when fda approve compass pathways' comp360 psilocybin. Best Yes near 76¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 76¢ · Best No: 31¢ · 1 platform
- Kalshi: Yes 76¢ / No 31¢
LIVE
Before July 2027
Volume
$7.5K
$5 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Jul 1, 2027
~380 days left
Category
Culture
Yes
76¢
Kalshi
No
31¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platformPrice History
Loading…
About This Market
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jul 1, 2027, then the market resolves to Yes.
Market Details
ResolutionResolves Jul 1, 2027
Time Left380 days
Status● Active
CategoryCulture
Yes
76¢
Kalshi
Payout 1.3x
No
31¢
Kalshi
Payout 3.2x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In